Fate alert: bragar eagel & squire, p.c. is investigating fate therapeutics, inc. on behalf of long-term stockholders and encourages investors to contact the firm

New york--(business wire)-- #a--bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against fate therapeutics, inc. (nasdaq: fate) on behalf of long-term stockholders following a class action complaint that was filed against fate on january 20, 2023 with a class period from april 2, 2020 to january 5, 2023. our investigation concerns whether the board of directors of fate have breached their fiduciary duties to the company. on april.
FATE Ratings Summary
FATE Quant Ranking